Nano Holdings, Inc. (TYO:4571)

Japan · Delayed Price · Currency is JPY

77.00

-2.00 (-2.53%)

Oct 26, 2026, 3:30 PM JST

Market Cap	6.98B -41.8%
Revenue (ttm)	202.00M +75.7%
Net Income	-1.02B
EPS	-13.43
Shares Out	90.70M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	286,600
Open	79.00
Previous Close	79.00
Day's Range	76.00 - 79.00
52-Week Range	72.00 - 195.00
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Nano Holdings

Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company’s pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato,... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1996

Employees 23

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4571

Full Company Profile

Financial Performance

In fiscal year 2026, Nano Holdings's revenue was 174.00 million, an increase of 61.11% compared to the previous year's 108.00 million. Losses were -943.00 million, 12.9% more than in 2025.

Financial Statements